OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hidradenitis suppurativa: new insights into disease mechanisms and an evolving treatment landscape
James G. Krueger, John W. Frew, Gregor B. E. Jemec, et al.
British Journal of Dermatology (2023) Vol. 190, Iss. 2, pp. 149-162
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Hidradenitis Suppurativa
James P. Pham, John W. Frew
Dermatologic Clinics (2025) Vol. 43, Iss. 2, pp. 179-191
Closed Access | Times Cited: 3

Unravelling the complex pathogenesis of hidradenitis suppurativa
John W. Frew
British Journal of Dermatology (2025) Vol. 192, Iss. Supplement_1, pp. i3-i14
Open Access | Times Cited: 2

Drug survival of biologics in hidradenitis suppurativa: A systematic review and meta-analysis
James P. Pham, Nana Aviaaja Lippert Rosenø, Gabriele Roccuzzo, et al.
Journal of the American Academy of Dermatology (2024) Vol. 91, Iss. 1, pp. 170-172
Open Access | Times Cited: 6

Pathogenesis of Inflammation in Skin Disease: From Molecular Mechanisms to Pathology
Simona N. Shirley, Abigail E. Watson, Nabiha Yusuf
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10152-10152
Open Access | Times Cited: 5

Innate Immune Sensors and Cell Death—Frontiers Coordinating Homeostasis, Immunity, and Inflammation in Skin
Ye Mon Soe, Seen Ling Sim, Snehlata Kumari
Viruses (2025) Vol. 17, Iss. 2, pp. 241-241
Open Access

Place des antibiotiques à diffusion systémique dans la prise en charge de la maladie de Verneuil
Olivier Join‐Lambert, C. Fite, M. Delage, et al.
Annales de Dermatologie et de Vénéréologie - FMC (2025) Vol. 5, Iss. 2, pp. 2S14-2S20
Closed Access

Faut-il traiter précocement l'hidradénite suppurée avec des biologiques ou des petites molécules ?
C. Hotz
Annales de Dermatologie et de Vénéréologie - FMC (2025) Vol. 5, Iss. 2, pp. 2S7-2S13
Closed Access

The preclinical discovery and development of secukinumab for the treatment of moderate-to-severe hidradenitis suppurativa
Klaudia Knecht-Gurwin, Łukasz Matusiak, Jacek C. Szepietowski
Expert Opinion on Drug Discovery (2025)
Closed Access

The role of interleukin inhibitors in the treatment of hidradenitis suppurativa; a systematic review of clinical trials
Nazila Heidari, Amirhossein Heidari, Sara Eghbali, et al.
Autoimmunity Reviews (2025), pp. 103818-103818
Closed Access

Apocrine gland damage and the release of specific keratins in early stage indicate the crucial involvement of apocrine glands in hidradenitis suppurativa
Jiaqi Li, Sitong Li, Qiujing Zhang, et al.
Journal of Investigative Dermatology (2024)
Closed Access | Times Cited: 3

CD2 expressing innate lymphoid and T cells are critical effectors of immunopathogenesis in hidradenitis suppurativa
Mahendra Kashyap, Bharat Mishra, R. Sinha, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 48
Closed Access | Times Cited: 3

Eosinophils in hidradenitis suppurativa patients exhibit pro‐inflammatory traits, implicating a potential pathogenic role in the disease
Yael Renert‐Yuval, Juana Gonzalez, Sandra Garcet, et al.
Experimental Dermatology (2024) Vol. 33, Iss. 7
Open Access | Times Cited: 2

Discrepancies in hidradenitis suppurativa lesion characterization by providers and patients
Lindsey Greenlund, Claire Herzog, Zachary Wendland, et al.
Journal of the European Academy of Dermatology and Venereology (2024)
Closed Access | Times Cited: 1

Intrinsic factors in the pathogenesis of hidradenitis suppurativa: Genetics, hormones, and the microbiome
John W. Frew
Journal of the American Academy of Dermatology (2024) Vol. 91, Iss. 6, pp. S12-S16
Closed Access

Selective small molecule inhibitors for hidradenitis suppurativa: Today and tomorrow
Daniella Jaguan, Kim Thuy Nguyen, Noah Goldfarb
Journal of the American Academy of Dermatology (2024) Vol. 91, Iss. 6, pp. S31-S36
Closed Access

Harnessing artificial intelligence for advancing early diagnosis in hidradenitis suppurativa
Sérgio Crovella, Muhammad Suleman, Paola Maura Tricarico, et al.
Italian Journal of Dermatology and Venereology (2024) Vol. 159, Iss. 1
Closed Access

Setting the Stage for Standardized Reporting of Clinical and Demographic Information in Laboratory-Based Studies of Hidradenitis Suppurativa
Stephanie L Schell, Amanda M. Nelson
Journal of Investigative Dermatology (2024) Vol. 144, Iss. 8, pp. 1689-1695
Closed Access

Small molecule inhibitors – future perspectives in the treatment of hidradenitis suppurativa (HS)
Krisztián Németh, Hajnalka Jókai
Bőrgyógyászati és Venerológiai Szemle (2024) Vol. 100, Iss. 3, pp. 131-142
Open Access

Expanding the frontiers of therapeutic options in hidradenitis suppurativa: The valid contribution of bimekizumab
Elisa Molinelli, Edoardo De Simoni, Oriana Simonetti
Med (2024) Vol. 5, Iss. 10, pp. 1197-1199
Closed Access

Navigating the current revolution in hidradenitis suppurativa care and research
Christopher Sayed, Jennifer L. Hsiao
Journal of the American Academy of Dermatology (2024) Vol. 91, Iss. 6, pp. S1-S2
Closed Access

Page 1 - Next Page

Scroll to top